Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
-898K
-
Total reported value, excl. options
-
$4.61B
-
Value change
-
-$20M
-
Put/Call ratio
-
0.46
-
Number of buys
-
120
-
Number of sells
-
-138
-
Price
-
$32.92
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2020
315 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q3 2020.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
of 334M outstanding shares and own 41.84% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11.8M shares), PERCEPTIVE ADVISORS LLC (10.1M shares), Avoro Capital Advisors LLC (9.54M shares), BlackRock Inc. (9.14M shares), FRANKLIN RESOURCES INC (8.32M shares), ARK Investment Management LLC (7.9M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.93M shares), ORBIMED ADVISORS LLC (6.65M shares), FARALLON CAPITAL MANAGEMENT LLC (5.96M shares), and GREAT POINT PARTNERS LLC (3.88M shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.